模型平均/选择方法提升模型引导精准给药的预测性能:万古霉素案例研究
该研究基于万古霉素案例,开发并评估了模型选择算法(MSA)和模型平均算法(MAA),并在MIPD软件「TDMx」中实现。在六个人群模拟和180例患者临床数据中,MSA和MAA相比单一模型展现出更准确的预测性能,可简化MIPD并降低模型验证负担。
要点
- MSA和MAA在模拟人群中预测不精确度9.9-24.2%,不准确度小于±8.2%,优于单一模型。
- 临床数据中单一模型预测性能差异大,MSA和MAA联合多模型实现无偏且精确的预测。
- MSA和MAA可降低个体模型验证负担,简化模型引导精准给药流程。
核心结论
- MSA和MAA相比单一模型能改善万古霉素模型引导精准给药的预测性能。
研究设计与样本
- 研究基于万古霉素案例,衍生并评估模型选择算法(MSA)和模型平均算法(MAA),并在MIPD软件「TDMx」中实现。
- 评估包括六个人群的模拟研究和180例接受万古霉素治疗并做TDM的临床数据集,比较两种算法与单一模型的预测性能(基于准确度和精密度)。
主要发现
- 在六个虚拟人群中,MSA和MAA的不精密度为9.9-24.2%,不准确度小于±8.2%,而单一模型的不精密度为8.9-51.1%,不准确度高达28.9%。
- 在临床数据集中,应用至少一个血浆浓度的单一模型预测性能差异大(不精密度28-62%,不准确度-16至25%)。
- 同时使用这些模型的MSA或MAA产生无偏且精确的预测(不精密度分别为29%和30%,不准确度分别为-5%和0%)。
临床怎么用
- 在TDMx中实现MSA和MAA可能降低个体模型适配验证的负担并简化MIPD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many important drugs exhibit substantial variability in pharmacokinetics and pharmacodynamics leading to a loss of the desired clinical outcomes or significant adverse effects. Forecasting drug exposures using pharmacometric models can improve individual target attainment when compared with conventional therapeutic drug monitoring (TDM). However, selecting the "correct" model for this model-informed precision dosing (MIPD) is challenging. We derived and evaluated a model selection algorithm (MSA) and a model averaging algorithm (MAA), which automates model selection and finds the best model or combination of models for each patient using vancomycin as a case study, and implemented both algorithms in the MIPD software "TDMx." The predictive performance (based on accuracy and precision) of the two algorithms was assessed in (i) a simulation study of six distinct populations and (ii) a clinical dataset of 180 patients undergoing TDM during vancomycin treatment and compared with the performance obtained using a single model. Throughout the six virtual populations the MSA and MAA (imprecision: 9.9-24.2%, inaccuracy: less than ± 8.2%) displayed more accurate predictions than the single models (imprecision: 8.9-51.1%; inaccuracy: up to 28.9%). In the clinical dataset, the predictive performance of the single models applying at least one plasma concentration varied substantially (imprecision: 28-62%, inaccuracy: -16 to 25%), whereas the MSA or MAA utilizing these models simultaneously resulted in unbiased and precise predictions (imprecision: 29% and 30%, inaccuracy: -5% and 0%, respectively). MSA and MAA approaches implemented in TDMx might thereby lower the burden of fit-for-purpose validation of individual models and streamline MIPD.
引用
- Uster DW, Stocker SL, Carland JE, et al. A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study. Clin Pharmacol Ther. 2020. PMID: 32996120. doi:10.1002/cpt.2065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。